Product	Indication	USDMF	EDMF / COS
Acetazolamide	Glaucoma	Available	-
Acamprosate Calcium	Alcohol abstinence	Planned in Q1-2012	-
Amlexanox	NSAID	-	-
Amtolmetin Guacil	NSAID	-	-
Anastrazole	Oncology	Available	Planned in 2012
Aprepitant	Antiemetic	-	-
Arformoterol tartrate	Pulmonary	-	-
Argatroban monohydrate	Anticoagulant	Planned in Q1-2012	Planned in 2013
Bendamustine HCl	Oncology	Planned in 2012	Planned in 2012
Benzphetamine HCl	Obesity	Available	-
Bicalutamide	Oncology	Available	-
Busalfan	Oncology	Available	Planned in 2012
Carmustine	Oncology	Available	Available
Carprofen	NSAID	Available	Planned in 2012
Carvedilol	Cardiovascular	-	-
Cidofovir dihydrate	Antiviral	Available	Planned in 2012
Colesevelam HCI	Hyperlipidemia	Planned in 2012	Planned in 2012
Cyclophosphamide	Oncology	Available	Available
Dapoxetine HCl	SSRI	-	Planned in 2013
Deferiprone	Thalassemia	Available	-
Desvenlafaxine	Antidepressant	-	Planned in 2013
Docetaxel trihydrate	Oncology	Planned in Q1-2012	Planned in 2013
Dolasetron Mesylate	Antiemetic	Available	Planned in 2013
Dronedarone HCl	Cardiovascular	-	-
Efavirenz	ARV	Available	Planned in 2013
Emtricitabine	ARV	Available	Planned in 2012
Eslicarbazepine Acetate	Antiepileptic	-	-
Esomeprazole Sodium	Gastrointestinal	Available	Planned in 2012
Eszopiclone	Insomnia	Available	Available
Etodolac	NSAID	Planned in Q1-2012	Planned in 2013
Febuxostat	Gout	-	-
Felodipine	Hypertension	Available	-
Fenoprofen Calcium	NSAID	Available	-
Gemcitabine HCl	Oncology	Available	Planned in 2012
Ibandronate Sodium	Osteoporosis	Available	Available
Ibutilide Fumarate	Cardiovascular	Planned in Q1-2012	-
Iloperidone	Antipsychotic	-	-
Irinotecan HCl	Oncology	Available	Planned in 2012
Iron Dextran Complex	Haematinic	Planned in 2012	-
Iron Polymaltose Complex	Haematinic	-	-
Iron Sucrose Complex	Haematinic	Planned in 2012	Planned in 2012
Ketoprofen	NSAID	-	-
Lafutidine	Anti-ulcer	-	Planned in 2013
Lamotrigine	Antiepileptic	-	-
Levocetirizine di HCl	Anti-histaminic	-	-
Levosulpiride	Antipsychotic	-	-
Lumefantrine	Antimalarial	Planned in 2012	Planned in 2013
Mefloquine HCl	Antimalarial	Available	Planned in 2012
Melphalan HCl	Oncology	Available	-
Memantine HCl	Alzheimer's	Available	Planned in 2012
Mycophenolate Mofetil	Immunosuppressant	Planned in Q1-2012	-
Mycophenolate Sodium	Immunosuppressant	-	-
Nisoldipine	Cardiovascular	Planned in Q1-2012	-
Olanzapine	Antipsychotic	-	Planned in 2012
Olsalazine Sodium	Anti-inflammatory	Available	-
Oxaliplatin	Oncology	Available	-
Oxaprozin Potassium	NSAID	-	-
Palonosetron HCl	Nausea & Vomiting	Available	Planned in 2012
Pregabalin	Anticonvulsant	-	-
Promethazine HCl	Antihistamine	Planned in Q1-2012	-
Propafenone HCl	Cardiovascular	Planned in Q1-2012	Planned in 2013
Protriptylene HCl	Antidepressant	Available	-
Ritonavir	ARV	Available	Available
Rivastigmine Tartrate	Alzheimer's dementia	Available	Planned in 2013
Rizatriptan	Antimigraine	Planned in Q1-2012	-
Sevelamar HCl	Nephrology	Available	Available
Sevelamer Carbonate	Nephrology	Available	Available
Sodium Ferric Gluconate Complex	Haematinic	Available	Planned in 2013
Tenofovir disoproxil Fumarate	ARV	Available	Planned in 2012
Topiramate	Anticonvulsant	-	-
Topotecan HCl	Oncology	Available	Planned in 2012
Troxipide	Anti-ulcer	-	Planned in 2013
Zileuton	Anti-asthamatic	Planned in Q1-2012	-
Zoledronic acid	Osteoporosis	Available	Planned in 2012
Disclaimer: Any offer for product/service shall be subject to evaluation of relevant patent status.
Products which are already under specific licensing agreements are not offered to others.